Torrente L, Prieto Farigua N, Falzone A, Elkins C, Boothman D, Haura E, et al. Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone. Redox Biol. 2020;30:101440 pubmed publisher

Liu C, Zhao Y, Wang J, Yang Y, Zhang Y, Qu X, et al. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway. Cancer Lett. 2020;470:29-42 pubmed publisher

Park W. Upregulation of thioredoxin and its reductase attenuates arsenic trioxide‑induced growth suppression in human pulmonary artery smooth muscle cells by reducing oxidative stress. Oncol Rep. 2020;43:358-367 pubmed publisher

Sousa S, Leitão J, Silva R, Belo D, Santos I, Guerreiro J, et al. On the path to gold: Monoanionic Au bisdithiolate complexes with antimicrobial and antitumor activities. J Inorg Biochem. 2020;202:110904 pubmed publisher

Dogar I, Dixon S, Gill R, Young A, Mallay S, Oldford C, et al. C57BL/6J mice upregulate catalase to maintain the hydrogen peroxide buffering capacity of liver mitochondria. Free Radic Biol Med. 2020;146:59-69 pubmed publisher

Shu N, Cheng Q, Arner E, Davies M. Inhibition and crosslinking of the selenoprotein thioredoxin reductase-1 by p-benzoquinone. Redox Biol. 2020;28:101335 pubmed publisher

Sze J, Raninga P, Nakamura K, Casey M, Khanna K, Berners Price S, et al. Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma. Redox Biol. 2020;28:101310 pubmed publisher

Saei A, Beusch C, Chernobrovkin A, Sabatier P, Zhang B, Tokat Ü, et al. ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery. Nat Commun. 2019;10:5715 pubmed publisher

Tapfuma K, Uche Okereafor N, Sebola T, Hussan R, Mekuto L, Makatini M, et al. Cytotoxic activity of crude extracts from Datura stramonium's fungal endophytes against A549 lung carcinoma and UMG87 glioblastoma cell lines and LC-QTOF-MS/MS based metabolite profiling. BMC Complement Altern Med. 2019;19:330 pubmed publisher

Tian S, Siu F, Lok C, Fung Y, Che C. Anticancer auranofin engages 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) as a target. Metallomics. 2019;11:1925-1936 pubmed publisher

Mi ichi F, Ishikawa T, Tam V, Deloer S, Hamano S, Hamada T, et al. Characterization of Entamoeba histolytica adenosine 5'-phosphosulfate (APS) kinase; validation as a target and provision of leads for the development of new drugs against amoebiasis. PLoS Negl Trop Dis. 2019;13:e0007633 pubmed publisher

Diaz R, Shytaj I, Giron L, Obermaier B, Della Libera E, Galinskas J, et al. Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial. Int J Antimicrob Agents. 2019;54:592-600 pubmed publisher

Tharmalingam N, Ribeiro N, da Silva D, Naik M, Cruz L, Kim W, et al. Auranofin is an effective agent against clinical isolates of Staphylococcus aureus. Future Med Chem. 2019;11:1417-1425 pubmed publisher

Thome T, Salyers Z, Kumar R, Hahn D, Berru F, Ferreira L, et al. Uremic metabolites impair skeletal muscle mitochondrial energetics through disruption of the electron transport system and matrix dehydrogenase activity. Am J Physiol Cell Physiol. 2019;317:C701-C713 pubmed publisher

Li X, Zhang B, Yan C, Li J, Wang S, Wei X, et al. A fast and specific fluorescent probe for thioredoxin reductase that works via disulphide bond cleavage. Nat Commun. 2019;10:2745 pubmed publisher

Halatsch M, Kast R, Dwucet A, Hlavac M, Heiland T, Westhoff M, et al. Bcl-2/Bcl-xL inhibition predominantly synergistically enhances the anti-neoplastic activity of a low-dose CUSP9 repurposed drug regime against glioblastoma. Br J Pharmacol. 2019;176:3681-3694 pubmed publisher

Chantzi E, Jarvius M, Niklasson M, Segerman A, Gustafsson M. COMBImage2: a parallel computational framework for higher-order drug combination analysis that includes automated plate design, matched filter based object counting and temporal data mining. BMC Bioinformatics. 2019;20:304 pubmed publisher

Ward D, van de Langemheen H, Koehne E, Kreidenweiss A, Liskamp R. Highly tunable thiosulfonates as a novel class of cysteine protease inhibitors with anti-parasitic activity against Schistosoma mansoni. Bioorg Med Chem. 2019;: pubmed publisher

Xu H, Li C, Mozziconacci O, Zhu R, Xu Y, Tang Y, et al. Xanthine oxidase-mediated oxidative stress promotes cancer cell-specific apoptosis. Free Radic Biol Med. 2019;: pubmed publisher

Jang H, Eom Y. Repurposing auranofin to combat uropathogenic Escherichia coli biofilms. J Appl Microbiol. 2019;127:459-471 pubmed publisher

Kuo D, Ding J, Cohn I, Zhang F, Wei K, Rao D, et al. HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness. Sci Transl Med. 2019;11: pubmed publisher

Rajavel T, Banu Priya G, Suryanarayanan V, Singh S, Pandima Devi K. Daucosterol disturbs redox homeostasis and elicits oxidative-stress mediated apoptosis in A549 cells via targeting thioredoxin reductase by a p53 dependent mechanism. Eur J Pharmacol. 2019;855:112-123 pubmed publisher

Skaga E, Skaga I, Grieg Z, Sandberg C, Langmoen I, Vik Mo E. The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy. J Cancer Res Clin Oncol. 2019;145:1495-1507 pubmed publisher

Zhang X, Selvaraju K, Saei A, D Arcy P, Zubarev R, Arnér E, et al. Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug. Biochimie. 2019;162:46-54 pubmed publisher

Nag D, Bhanja P, Riha R, Sanchez Guerrero G, Kimler B, Tsue T, et al. Auranofin Protects Intestine against Radiation Injury by Modulating p53/p21 Pathway and Radiosensitizes Human Colon Tumor. Clin Cancer Res. 2019;: pubmed publisher

Fidyt K, Pastorczak A, Góral A, Szczygiel K, Fendler W, Muchowicz A, et al. Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia. Mol Oncol. 2019;13:1180-1195 pubmed publisher

Elhassanny A, Ladin D, Soliman E, Albassam H, Morris A, Kobet R, et al. Prostaglandin D2-ethanolamide induces skin cancer apoptosis by suppressing the activity of cellular antioxidants. Prostaglandins Other Lipid Mediat. 2019;142:9-23 pubmed publisher

Liu X, Wang W, Yin Y, Li M, Li H, Xiang H, et al. A high-throughput drug screen identifies auranofin as a potential sensitizer of cisplatin in small cell lung cancer. Invest New Drugs. 2019;: pubmed publisher

Mao Z, Huang Y, Zhang Z, Yang X, Zhang X, Huang Y, et al. Pharmacological levels of hydrogen sulfide inhibit oxidative cell injury through regulating the redox state of thioredoxin. Free Radic Biol Med. 2019;134:190-199 pubmed publisher

Chen X, Chen X, Zhang X, Wang L, Cao P, Rajamanickam V, et al. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells. Redox Biol. 2019;21:101061 pubmed publisher

Shokhina A, Kostyuk A, Ermakova Y, Panova A, Staroverov D, Egorov E, et al. Red fluorescent redox-sensitive biosensor Grx1-roCherry. Redox Biol. 2019;21:101071 pubmed publisher

Abdelkhalek A, Abutaleb N, Mohammad H, Seleem M. Antibacterial and antivirulence activities of auranofin against Clostridium difficile. Int J Antimicrob Agents. 2019;53:54-62 pubmed publisher

Turcano L, Torrente E, Missineo A, Andreini M, Gramiccia M, Di Muccio T, et al. Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening. PLoS Negl Trop Dis. 2018;12:e0006969 pubmed publisher

Cecchinato V, D Agostino G, Raeli L, Nerviani A, Schiraldi M, Danelon G, et al. Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis. Front Immunol. 2018;9:2118 pubmed publisher

Ferguson D, Smerdon G, Harries L, Dodd N, Murphy M, Curnow A, et al. Altered cellular redox homeostasis and redox responses under standard oxygen cell culture conditions versus physioxia. Free Radic Biol Med. 2018;126:322-333 pubmed publisher

Mi ichi F, Miyake Y, Tam V, Yoshida H. A Flow Cytometry Method for Dissecting the Cell Differentiation Process of Entamoeba Encystation. Front Cell Infect Microbiol. 2018;8:250 pubmed publisher

Hu J, Zhang H, Cao M, Wang L, Wu S, Fang B. Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma. Mol Cancer Ther. 2018;17:2156-2163 pubmed publisher

Dunigan K, Li Q, Li R, Locy M, Wall S, Tipple T. The thioredoxin reductase inhibitor auranofin induces heme oxygenase-1 in lung epithelial cells via Nrf2-dependent mechanisms. Am J Physiol Lung Cell Mol Physiol. 2018;315:L545-L552 pubmed publisher

Hasam Henderson L, Gotti G, Mishto M, Klisch C, Gerevich Z, Geiger J, et al. NMDA-receptor inhibition and oxidative stress during hippocampal maturation differentially alter parvalbumin expression and gamma-band activity. Sci Rep. 2018;8:9545 pubmed publisher

Fernandez M, O Flaherty C. Peroxiredoxin 6 is the primary antioxidant enzyme for the maintenance of viability and DNA integrity in human spermatozoa. Hum Reprod. 2018;33:1394-1407 pubmed publisher

Chortis V, Taylor A, Doig C, Walsh M, Meimaridou E, Jenkinson C, et al. Nicotinamide Nucleotide Transhydrogenase as a Novel Treatment Target in Adrenocortical Carcinoma. Endocrinology. 2018;159:2836-2849 pubmed publisher

Abdelkhalek A, Abutaleb N, Elmagarmid K, Seleem M. Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci. Sci Rep. 2018;8:8353 pubmed publisher

Kamunde C, Sharaf M, MacDonald N. H2O2 metabolism in liver and heart mitochondria: Low emitting-high scavenging and high emitting-low scavenging systems. Free Radic Biol Med. 2018;124:135-148 pubmed publisher

Elie B, Pechenyy Y, Uddin F, Contel M. A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer. J Biol Inorg Chem. 2018;23:399-411 pubmed publisher

Ssemaganda A, Low L, Verhoeft K, Wambuzi M, Kawoozo B, Nabasumba S, et al. Gold(i) phosphine compounds as parasite attenuating agents for malaria vaccine and drug development. Metallomics. 2018;10:444-454 pubmed publisher

Carroll B, Otten E, Manni D, Stefanatos R, Menzies F, Smith G, et al. Oxidation of SQSTM1/p62 mediates the link between redox state and protein homeostasis. Nat Commun. 2018;9:256 pubmed publisher

Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, et al. Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis. Cell. 2018;172:409-422.e21 pubmed publisher

Xiao J, Rijal P, Schimanski L, Tharkeshwar A, Wright E, Annaert W, et al. Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein. J Virol. 2018;92: pubmed publisher

Stöcker S, Maurer M, Ruppert T, Dick T. A role for 2-Cys peroxiredoxins in facilitating cytosolic protein thiol oxidation. Nat Chem Biol. 2017;: pubmed publisher

Schultz M, Diaz A, Smite S, Lay A, DeCant B, McKinney R, et al. Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancer. Oncotarget. 2017;8:92667-92681 pubmed publisher

Baek H, Park N, Kwon Y, Ye D, Shin S, Chun Y. Annexin A5 suppresses cyclooxygenase-2 expression by downregulating the protein kinase C-?-nuclear factor-?B signaling pathway in prostate cancer cells. Oncotarget. 2017;8:74263-74275 pubmed publisher

Romero R, Sayin V, Davidson S, Bauer M, Singh S, LeBoeuf S, et al. Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nat Med. 2017;23:1362-1368 pubmed publisher

Malone C, Emerson C, Ingraham R, Barbosa W, Guerra S, Yoon H, et al. mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven Tumors. Cancer Discov. 2017;7:1450-1463 pubmed publisher

Leitsch D. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial. Int J Parasitol Drugs Drug Resist. 2017;7:321-327 pubmed publisher

Hall S, Toulany J, Bennett L, Martinez Farina C, Robertson A, Jakeman D, et al. Jadomycins Inhibit Type II Topoisomerases and Promote DNA Damage and Apoptosis in Multidrug-Resistant Triple-Negative Breast Cancer Cells. J Pharmacol Exp Ther. 2017;363:196-210 pubmed publisher

Karwaciak I, Gorzkiewicz M, Bartosz G, Pulaski L. TLR2 activation induces antioxidant defence in human monocyte-macrophage cell line models. Oncotarget. 2017;8:54243-54264 pubmed publisher

Sajman J, Trus M, Atlas D, Sherman E. The L-type Voltage-Gated Calcium Channel co-localizes with Syntaxin 1A in nano-clusters at the plasma membrane. Sci Rep. 2017;7:11350 pubmed publisher

Narayan S, Nishtala P. Development and validation of a Medicines Comorbidity Index for older people. Eur J Clin Pharmacol. 2017;73:1665-1672 pubmed publisher

Bae J, Lee J, Park Y, Park K, Kim J, Cho D, et al. Attenuation of MUC4 potentiates the anticancer activity of auranofin via regulation of the Her2/Akt/FOXO3 pathway in ovarian cancer cells. Oncol Rep. 2017;38:2417-2425 pubmed publisher

Trommenschlager A, Chotard F, Bertrand B, Amor S, Dondaine L, Picquet M, et al. Gold(i)-BODIPY-imidazole bimetallic complexes as new potential anti-inflammatory and anticancer trackable agents. Dalton Trans. 2017;46:8051-8056 pubmed publisher

Lee J, Kwon Y, Baek H, Ye D, Cho E, Choi H, et al. Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells. Arch Pharm Res. 2017;40:746-759 pubmed publisher

Jelcic M, Enyedi B, Xavier J, Niethammer P. Image-Based Measurement of H2O2 Reaction-Diffusion in Wounded Zebrafish Larvae. Biophys J. 2017;112:2011-2018 pubmed publisher

Nagakannan P, Eftekharpour E. Differential redox sensitivity of cathepsin B and L holds the key to autophagy-apoptosis interplay after Thioredoxin reductase inhibition in nutritionally stressed SH-SY5Y cells. Free Radic Biol Med. 2017;108:819-831 pubmed publisher

Sciegienka S, Solst S, Falls K, Schoenfeld J, Klinger A, Ross N, et al. D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H2O2-mediated oxidative stress. Free Radic Biol Med. 2017;108:354-361 pubmed publisher

Kipp A, Deubel S, Arnér E, Johansson K. Time- and cell-resolved dynamics of redox-sensitive Nrf2, HIF and NF-κB activities in 3D spheroids enriched for cancer stem cells. Redox Biol. 2017;12:403-409 pubmed publisher

Oh B, Lee S, Cho H, Park Y, Kim J, Yoon S, et al. Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer. Cell Death Dis. 2017;8:e2682 pubmed publisher

Massai L, Messori L, Micale N, Schirmeister T, Maes L, Fregona D, et al. Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents. Biometals. 2017;30:313-320 pubmed publisher

Hwang Bo H, Jeong J, Han M, Park C, Hong S, Kim G, et al. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species. Gen Physiol Biophys. 2017;36:117-128 pubmed publisher

Kang J, Kim G, Kim B, Choi Y. Antioxidative effects of diallyl trisulfide on hydrogen peroxide-induced cytotoxicity through regulation of nuclear factor-E2-related factor-mediated thioredoxin reductase 1 expression in C2C12 skeletal muscle myoblast cells. Gen Physiol Biophys. 2017;36:129-139 pubmed publisher

Warzajtis B, Glišić B, Savić N, Pavic A, Vojnovic S, Veselinović A, et al. Mononuclear gold(iii) complexes with l-histidine-containing dipeptides: tuning the structural and biological properties by variation of the N-terminal amino acid and counter anion. Dalton Trans. 2017;46:2594-2608 pubmed publisher

Poet G, Oka O, van Lith M, Cao Z, Robinson P, Pringle M, et al. Cytosolic thioredoxin reductase 1 is required for correct disulfide formation in the ER. EMBO J. 2017;36:693-702 pubmed publisher

Suzuki S, Ogawa M, Ohta S, Nunomura S, Nanri Y, Shiraishi H, et al. Induction of Airway Allergic Inflammation by Hypothiocyanite via Epithelial Cells. J Biol Chem. 2016;291:27219-27227 pubmed publisher

Chen X, Tzekov R, Su M, Hong H, Min W, Han A, et al. Auranofin Inhibits Retinal Pigment Epithelium Cell Survival through Reactive Oxygen Species-Dependent Epidermal Growth Factor Receptor/ Mitogen-Activated Protein Kinase Signaling Pathway. PLoS ONE. 2016;11:e0166386 pubmed publisher

Zhang J, Yao J, Peng S, Li X, Fang J. Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase. Biochim Biophys Acta Mol Basis Dis. 2017;1863:129-138 pubmed publisher

Filipczak P, Thomas C, Chen W, Salzman A, McDonald J, Lin Y, et al. TSC2 Deficiency Unmasks a Novel Necrosis Pathway That Is Suppressed by the RIP1/RIP3/MLKL Signaling Cascade. Cancer Res. 2016;76:7130-7139 pubmed

Roh J, Jang H, Kim E, Shin D. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer. Antioxid Redox Signal. 2017;27:106-114 pubmed publisher

Nagakannan P, Iqbal M, Yeung A, Thliveris J, Rastegar M, Ghavami S, et al. Perturbation of redox balance after thioredoxin reductase deficiency interrupts autophagy-lysosomal degradation pathway and enhances cell death in nutritionally stressed SH-SY5Y cells. Free Radic Biol Med. 2016;101:53-70 pubmed publisher

Leitsch D, Muller J, Muller N. Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target. Int J Parasitol Drugs Drug Resist. 2016;6:148-153 pubmed publisher

Thangamani S, Mohammad H, Abushahba M, Sobreira T, Hedrick V, PAUL L, et al. Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens. Sci Rep. 2016;6:22571 pubmed publisher

Haß C, Belz K, Schoeneberger H, Fulda S. Sensitization of acute lymphoblastic leukemia cells for LCL161-induced cell death by targeting redox homeostasis. Biochem Pharmacol. 2016;105:14-22 pubmed publisher

Li H, Hu J, Wu S, Wang L, Cao X, Zhang X, et al. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells. Oncotarget. 2016;7:3548-58 pubmed publisher

Manhas R, Gowri V, Madhubala R. Leishmania donovani Encodes a Functional Selenocysteinyl-tRNA Synthase. J Biol Chem. 2016;291:1203-20 pubmed publisher

Topkas E, Cai N, Cumming A, Hazar Rethinam M, Gannon O, Burgess M, et al. Auranofin is a potent suppressor of osteosarcoma metastasis. Oncotarget. 2016;7:831-44 pubmed publisher

You B, Park W. Auranofin induces mesothelioma cell death through oxidative stress and GSH depletion. Oncol Rep. 2016;35:546-51 pubmed publisher

Zou P, Chen M, Ji J, Chen W, Chen X, Ying S, et al. Auranofin induces apoptosis by ROS-mediated ER stress and mitochondrial dysfunction and displayed synergistic lethality with piperlongumine in gastric cancer. Oncotarget. 2015;6:36505-21 pubmed publisher

Nguyen T, Østergaard J, Gammelgaard B. A method for studies on interactions between a gold-based drug and plasma proteins based on capillary electrophoresis with inductively coupled plasma mass spectrometry detection. Anal Bioanal Chem. 2015;407:8497-503 pubmed publisher

Kaiser M, Maser P, Tadoori L, Ioset J, Brun R. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning. PLoS ONE. 2015;10:e0135556 pubmed publisher

Tsai L, Xie L, Doré K, Xie L, Del Rio J, King C, et al. Zeta Inhibitory Peptide Disrupts Electrostatic Interactions That Maintain Atypical Protein Kinase C in Its Active Conformation on the Scaffold p62. J Biol Chem. 2015;290:21845-56 pubmed publisher

Hrabe J, O Leary B, Fath M, Rodman S, Button A, Domann F, et al. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells. Redox Biol. 2015;5:319-327 pubmed publisher

Sachweh M, Stafford W, Drummond C, McCarthy A, Higgins M, Campbell J, et al. Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells. Oncotarget. 2015;6:16488-506 pubmed

Zuverink M, Chen C, Przedpelski A, Blum F, Barbieri J. A Heterologous Reporter Defines the Role of the Tetanus Toxin Interchain Disulfide in Light-Chain Translocation. Infect Immun. 2015;83:2714-24 pubmed publisher

Edwards J, Brown M, Peak E, Bartholomew B, Nash R, Hoffmann K. The diterpenoid 7-keto-sempervirol, derived from Lycium chinense, displays anthelmintic activity against both Schistosoma mansoni and Fasciola hepatica. PLoS Negl Trop Dis. 2015;9:e0003604 pubmed publisher

Lalli C, Guidi A, Gennari N, Altamura S, Bresciani A, Ruberti G. Development and validation of a luminescence-based, medium-throughput assay for drug screening in Schistosoma mansoni. PLoS Negl Trop Dis. 2015;9:e0003484 pubmed publisher

Papaioannou M, Mylonas I, Kast R, Brüning A. Disulfiram/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition. Oncoscience. 2014;1:21-9 pubmed

Tian H, Zhang D, Zhang B, Li H, Zhang Q, Li L, et al. Melanoma differentiation associated gene-7/interleukin-24 induces caspase-3 denitrosylation to facilitate the activation of cancer cell apoptosis. J Interferon Cytokine Res. 2015;35:157-67 pubmed publisher

Park N, Chun Y. Auranofin promotes mitochondrial apoptosis by inducing annexin A5 expression and translocation in human prostate cancer cells. J Toxicol Environ Health A. 2014;77:1467-76 pubmed publisher

Vančo J, Gáliková J, Hosek J, Dvorak Z, Paráková L, Trávníček Z. Gold(I) complexes of 9-deazahypoxanthine as selective antitumor and anti-inflammatory agents. PLoS ONE. 2014;9:e109901 pubmed publisher

James L, Xu Z, Sluyter R, Hawksworth E, Kelso C, Lai B, et al. An investigation into the interactions of gold nanoparticles and anti-arthritic drugs with macrophages, and their reactivity towards thioredoxin reductase. J Inorg Biochem. 2015;142:28-38 pubmed publisher

Park S, Lee J, Berek J, Hu M. Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53. Int J Oncol. 2014;45:1691-8 pubmed publisher

Andrade R, Chaparro J, Capparelli E, Reed S. Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis. PLoS Negl Trop Dis. 2014;8:e2973 pubmed publisher

Suzuki H, Hatano N, Muraki Y, Itoh Y, Kimura S, Hayashi H, et al. The NADPH oxidase inhibitor diphenyleneiodonium activates the human TRPA1 nociceptor. Am J Physiol Cell Physiol. 2014;307:C384-94 pubmed publisher

Chen X, Zhou H, Huang Q, Lu L, Min W. Novel action and mechanism of auranofin in inhibition of vascular endothelial growth factor receptor-3-dependent lymphangiogenesis. Anticancer Agents Med Chem. 2014;14:946-54 pubmed

Sun K, Eriksson S, Tan Y, Zhang L, Arner E, Zhang J. Serum thioredoxin reductase levels increase in response to chemically induced acute liver injury. Biochim Biophys Acta. 2014;1840:2105-11 pubmed publisher

Hosek J, Vančo J, Starha P, Paráková L, Trávníček Z. Effect of 2-chloro-substitution of adenine moiety in mixed-ligand gold(I) triphenylphosphine complexes on anti-inflammatory activity: the discrepancy between the in vivo and in vitro models. PLoS ONE. 2013;8:e82441 pubmed publisher

Jaeger S, Schroeder B, Meyer Hoffert U, Courth L, Fehr S, Gersemann M, et al. Cell-mediated reduction of human ?-defensin 1: a major role for mucosal thioredoxin. Mucosal Immunol. 2013;6:1179-90 pubmed publisher

Bachnoff N, Cohen Kutner M, Trus M, Atlas D. Intra-membrane signaling between the voltage-gated Ca2+-channel and cysteine residues of syntaxin 1A coordinates synchronous release. Sci Rep. 2013;3:1620 pubmed publisher

Gadadhar S, Karande A. Abrin immunotoxin: targeted cytotoxicity and intracellular trafficking pathway. PLoS ONE. 2013;8:e58304 pubmed publisher

Kim N, Park H, Oh M, Kim I. Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cells. BMB Rep. 2013;46:59-64 pubmed

Qu Z, Miao W, Hu S, Li C, Zhuo X, Zong Y, et al. N-methyl-D-aspartate receptor-dependent denitrosylation of neuronal nitric oxide synthase increase the enzyme activity. PLoS ONE. 2012;7:e52788 pubmed publisher

Lopert P, Day B, Patel M. Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells. PLoS ONE. 2012;7:e50683 pubmed publisher

Debnath A, Parsonage D, Andrade R, He C, Cobo E, Hirata K, et al. A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target. Nat Med. 2012;18:956-60 pubmed publisher

Pearson S, Scarano W, Stenzel M. Micelles based on gold-glycopolymer complexes as new chemotherapy drug delivery agents. Chem Commun (Camb). 2012;48:4695-7 pubmed publisher

Song L, Li J, Xie S, Qian C, Wang J, Zhang W, et al. Thioredoxin glutathione reductase as a novel drug target: evidence from Schistosoma japonicum. PLoS ONE. 2012;7:e31456 pubmed publisher

Ilari A, Baiocco P, Messori L, Fiorillo A, Boffi A, Gramiccia M, et al. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition. Amino Acids. 2012;42:803-11 pubmed publisher

Peak E, Chalmers I, Hoffmann K. Development and validation of a quantitative, high-throughput, fluorescent-based bioassay to detect schistosoma viability. PLoS Negl Trop Dis. 2010;4:e759 pubmed publisher

Ting G, Schneeweiss S, Scranton R, Katz J, Weinblatt M, Young M, et al. Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study. Arthritis Res Ther. 2008;10:R95 pubmed publisher